Skip to main content

alpha-2A Adrenergic R/ADRA2A Antibody

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-22452

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-22452
NBP2-22452-0.025ml

Key Product Details

Validated by

Biological Validation

Species Reactivity

Validated:

Human, Mouse, Rat

Cited:

Rat

Applications

Validated:

Immunocytochemistry/ Immunofluorescence, Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot

Cited:

Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Rabbit IgG

Concentration

0.6 mg/ml

Product Specifications

Immunogen

Synthetic peptide corressponding to residues R(218) I Y Q I A K R R T R V P P S R R G(235) of the 3rd intracellular loop of human A2AAR.

Reactivity Notes

This antibody detects alpha-2A adrenergic receptor (A2AAR) from human, rat and mouse tissues.

Clonality

Polyclonal

Host

Rabbit

Isotype

IgG

Scientific Data Images for alpha-2A Adrenergic R/ADRA2A Antibody

Western Blot: alpha-2A Adrenergic R/ADRA2A Antibody [NBP2-22452]

Western Blot: alpha-2A Adrenergic R/ADRA2A Antibody [NBP2-22452]

Western Blot: alpha-2A Adrenergic R/ADRA2A Antibody [NBP2-22452] - Pooled lysates of laser-microdissected VMN nNOS- or GAD-immunopositive neurons from groups of female rats pretreated with V versus ER alpha or beta antagonist prior to intra-VMN V or NE infusion were analyzed by Western blot alpha-2A Adrenergic R/ADRA2A protein expression. Nitrergic neuron alpha2-,F(5, 12)=16.50,p<.0001 protein profiles are depicted in Panels 3B; GABAergic neuron alpha2-,F(5, 12)=10.47,p<.0001 protein profiles are presented in Panels 3E. Data show mean normalized protein O.D. measures+/-SEMfor the following treatment groups: Veh/Veh (n=6), MPP/Veh (n=6), PHTPP/Veh (n=6), Veh/NE (n=6), MPP/NE (n=6), and PHTPP/NE (n=6). *p<.05; **p<.01; ***p<.001. Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/32233668/) licensed under a CC-BY license.
Western Blot: alpha-2A Adrenergic R/ADRA2A Antibody [NBP2-22452]

Western Blot: alpha-2A Adrenergic R/ADRA2A Antibody [NBP2-22452]

Western Blot: alpha-2A Adrenergic R/ADRA2A Antibody [NBP2-22452] - Analysis was performed on whole cell extracts (30 ug lysate) of PC-3 (Lane 1), HEK-293 (Lane 2), T47D (Lane 3) and HEL 92.1.7 (lane 4). The blots were probed with Anti-alpha-2a Adrenergic Receptor Rabbit Polyclonal Antibody.
alpha-2A Adrenergic R/ADRA2A Antibody

Western Blot: alpha-2A Adrenergic R/ADRA2A Antibody [NBP2-22452] -

Western Blot: alpha-2A Adrenergic R/ADRA2A Antibody [NBP2-22452] - Effects of MPP Versus PHTPP on NE Regulation of VMN Nitrergic & GABA Neuron Adrenergic Receptor Protein Expression. Pooled lysates of laser-microdissected VMN nNOS- or GAD-immunopositive neurons from groups of female rats pretreated with V versus ER alpha or -beta antagonist prior to intra-VMN V or NE infusion were analyzed by Western blot for alpha1- ( alpha1-), alpha2- ( alpha2-), or beta1- ( beta1-) AR protein expression. Nitrergic neuron alpha1-, F(5, 12) = 10.51, p = .0005; alpha2-, F(5, 12) = 16.50, p < .0001; & beta1-, F(5, 12) = 11.72, p = .0003 protein profiles are depicted in Panels 3A to C; GABAergic neuron alpha1-, F(5, 12) = 5.52, p = .007; alpha2-, F(5, 12) = 10.47, p < .0001; & beta1-, F(5, 12) = 12.21, p = .0002 protein profiles are presented in Panels 3D to F. Data show mean normalized protein O.D. measures ± SEM for the following treatment groups: Veh/Veh (solid white bars, n = 6), MPP/Veh (diagonal-striped white bars, n = 6), PHTPP/Veh (cross-hatched white bars, n = 6), Veh/NE (solid gray bars, n = 6), MPP/NE (diagonal-striped gray bars, n = 6), & PHTPP/NE (cross-hatched gray bars, n = 6). *p < .05; **p < .01; ***p < .001. alpha1-AR = alpha1 adrenergic receptor; alpha2-AR = alpha2 adrenergic receptor; beta1-AR = beta1 adrenergic receptor; MPP = 1,3-Bis(4-hydroxyphenyl)-4-methyl-5-[4-(2-piperidinylethoxy)phenol]-1H-pyrazole dihydrochloride; PHTPP = 4-[2-phenyl-5,7-bis(trifluoromethyl)pyrazolo[1,5-a]pyrimidin-3-yl]phenol; NE = norepinephrine. Image collected & cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/32233668), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

Applications for alpha-2A Adrenergic R/ADRA2A Antibody

Application
Recommended Usage

Immunocytochemistry/ Immunofluorescence

0.25-2 ug/ml

Immunohistochemistry-Paraffin

1:1000

Western Blot

1:500

Formulation, Preparation, and Storage

Purification

Immunogen affinity purified

Formulation

PBS and 1 mg/ml BSA.

Preservative

0.05% Sodium Azide

Concentration

0.6 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at -20C. Avoid freeze-thaw cycles.

Background: alpha-2A Adrenergic R/ADRA2A

This study investigates the involvement of alpha2-adrenergic receptors (AR) in mouse brain induced by a low dose of methamphetamine (METH, 2 mg/kg). Immunohistochemical studies show that alpha2A-AR increased in the dentate gyrus area of the hippocampus 24 h after five repeated administrations of METH. The hippocampal alpha2A-AR proteins rose 3.2-fold when compared to the saline-administered mice. The other adrenergic receptor, alpha1D-AR, were not changed by the treatment. Moreover, alphao-subunits of GTP-binding proteins (Galphao), one of the downstream molecules of alpha2A-AR, was also increased by the treatment. These suggest that the repeated administration of low-doses of METH causes quantitative changes of the signaling of alpha2A-AR in the mouse hippocampus.

Long Name

Alpha-2A Adrenergic Receptor

Alternate Names

a-2A AdrenergicR, ADRA2A, alpha2A AdrenergicR, ZNF32

Entrez Gene IDs

150 (Human); 11551 (Mouse)

Gene Symbol

ADRA2A

Additional alpha-2A Adrenergic R/ADRA2A Products

Product Documents for alpha-2A Adrenergic R/ADRA2A Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for alpha-2A Adrenergic R/ADRA2A Antibody

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...